Cigna Corp. rose$. 97 or 1.1 percent, to $93.27. Humana Inc. rose$. 16 or. 1 percent, to $127.24. UnitedHealth Group rose$. 54 or. 7 percent, to $82.62.» Read More
The funds followed a federal agreement in April for New York to reinvest $8 billion in Medicaid savings to support hospital overhauls and expand primary medical care over five years.
WATERBURY, Conn.— Tenet Healthcare, which already is seeking to purchase a majority share of Waterbury Hospital, has announced plans to acquire Saint Mary's Hospital as well. Chad Wable, Saint Mary's president, tells the Republican-American newspaper the two hospitals would remain independent, but would share resources and services.
Cigna Corp. fell$. 71 or. 8 percent, to $91.72. Humana Inc. fell$. 72 or. 6 percent, to $127.55. UnitedHealth Group fell$. 57 or. 7 percent, to $81.66.
An unconventional but effective treatment against a deadly superbug is raising worries about a possible black market.
Cigna Corp. fell$. 51 or. 6 percent, to $91.92. Humana Inc. fell$. 79 or. 6 percent, to $127.48. UnitedHealth Group fell$. 64 or. 8 percent, to $81.58.
BATON ROUGE, La.— The Securities and Exchange Commission has wrapped up an investigation into Amedisys' participation in the federal Medicare program, and no enforcement actions will be recommended, the home health care and hospice services provider says.
Cigna Corp. rose$. 82 or. 9 percent, to $93.66. Humana Inc. rose$. 61 or. 5 percent, to $130.21. UnitedHealth Group rose$. 86 or 1.0 percent, to $83.35.
Cigna Corp. rose$. 84 or. 9 percent, to $93.68. Humana Inc. rose$. 68 or. 5 percent, to $130.28. UnitedHealth Group rose$. 86 or 1.0 percent, to $83.35.
Cigna Corp. rose$. 50 or. 5 percent, to $93.34. Humana Inc. rose$. 16 or. 1 percent, to $129.76. UnitedHealth Group rose$. 43 or. 5 percent, to $82.92.
WASHINGTON— The nation's largest pharmacy benefit manager, Express Scripts, is dramatically scaling back its coverage of compounded medications, saying most of the custom-mixed medicines are ineffective or overpriced.
LOUISVILLE, Ky.— Kindred Healthcare is urging Gentiva Health Services shareholders to support Kindred's latest acquisition bid, which faces opposition from both Gentiva's board and an anti-takeover measure the health and hospice service provider adopted last month.
July 1- Kindred Healthcare Inc pushed on with its hostile bid for Gentiva Health Services Inc, urging shareholders to ignore the home healthcare provider's board and vote for its $1.7 billion offer by July 16.
July 1- Kindred Healthcare Inc on Tuesday urged Gentiva Health Services Inc shareholders to vote for its offer to buy the home healthcare service provider.
June 30- Home healthcare service provider Gentiva Health Services Inc said its board had rejected an unsolicited offer from Kindred Healthcare Inc, saying the offer significantly undervalued the company.
NEW YORK, June 26- U.S. healthcare companies are winning higher profit forecasts, bucking a wider trend on Wall Street, as pricey new biotech drugs hit the market and insurance enrollment rises under the Affordable Care Act.
June 16- Hospital operator Kindred Healthcare Inc raised its offer for home healthcare services provider Gentiva Health Services Inc to $573 million, a little over three weeks after Gentiva said it adopted a poison pill to counter the hostile bid.
SAN FRANCISCO, June 12- Google Inc's futuristic eyeglasses are finding their way into hospitals and clinics throughout the United States.
June 3- Acadia Healthcare Co Inc, which operates psychiatric and substance-abuse clinics, said it would buy Partnerships in Care for about $660 million in cash, to enter the UK market. Partnerships in Care, the second largest provider of inpatient behavioral healthcare services in the UK, had revenue of about $285 million in 2013, Acadia said in a statement.
May 29- Ambulatory surgery center operator Amsurg Corp said it would buy Sheridan Healthcare Inc from private equity firm Hellman& Friedman LLC for about $2.35 billion in cash and stock to enter the outsourced physician services market.
May 28- Trimel Pharmaceuticals Corp said its experimental sexual disorder drug increased the average number of orgasms in women with an orgasmic disorder in a second mid-stage study. Trimel reported in February 2012 that the drug improved the occurrence of orgasms in a smaller mid-stage study conducted in a hospital setting.